IDD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innate Pharma SA

Watchlist Manager

Watchlist

Price: 1.302 EUR -0.76% Market Closed

Market Cap: €105.4m

	Innate Pharma SA F:IDD	FR
H	HAL Trust OTC:HALFF	NL
F	FirstGroup PLC F:FGR	UK
M	Megmilk Snow Brand Co Ltd F:6MG	JP
	Rural Funds Group F:J19	AU
E	East Africa Metals Inc OTC:EFRMF	CA
C	Children's Place Inc F:CP5	US

Profitability Summary

Innate Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

93% > 48%

Negative Operating Margin

-1 125%

Negative 3Y Average Operating Margin

-732%

Declining Operating Margin

-152% > -1 125%

Negative Net Margin

-1 122%

Negative 3Y Average Net Margin

-700%

Declining Net Margin

-144% > -1 122%

Negative Free Cash Flow Margin

-1 012%

Negative 3Y Average Free Cash Flow Margin

-635%

Declining Free Cash Flow Margin

-74% > -1 012%

Exceptional ROE

268%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-257%

Declining ROIC

-55% > -274%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.